Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir compound sulfate, identified by the CAS number 188062502 , is a crucial drug utilized in the treatment of HIV illness. Its mechanism of function involves inhibiting reverse transcriptase , a vital enzyme for viral copying. Patients receiving this pharmaceutical must undergo genetic examination prior to commencement, due to a risk of hypersensitivity reaction linked to the HLA-B*57:01 allele. This adverse effect can range from mild skin irritation to a severe, life-threatening syndrome . Careful monitoring and patient informing are therefore essential for safe and effective utilization of abacavir salt .

Abarelix: Exploring Compound 183552-38-7

Abarelix, identified as compound 183552-38-7, is a synthetic decapeptide developed for the management of benign prostatic hyperplasia . This drug functions as a specific gonadotropin-releasing hormone (GnRH) inhibitor, effectively suppressing male hormone production. Research into this agent has focused on its ability to lessen associated conditions and potentially provide an alternative to conventional interventions. AGOMELATINE 138112-76-2 The structural profile of 183552-38-7 is sophisticated , showcasing a particular amino acid sequence resulting in its targeted mechanism of impact. Further clinical trials are being conducted to completely evaluate its extended security and power.

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone acetate is a copyrightal blocker of CYP17A1, an protein crucial for testosterone biosynthesis. Its chemical formula is C26H30O3, and it’s frequently identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing the identifier for accurate identification. The compound's properties include high affinity for CYP17A1, resulting in lower androgen levels and exhibiting a white to off-white crystalline form appearance. Further analysis using analytical methods is usually conducted to establish identity and consistency.

CAS Number Spotlight: Abacavir Sulfate Salt – The CAS 188062-50-2

This article examines on a important pharmaceutical compound : Abacavir Sulfate , identified by its distinct Chemical Abstracts Service (CAS) designation: 188062-50-2. This drug is a essential part in the therapy of Human Immunodeficiency Virus infection, frequently used in conjunction other antiretroviral drugs. Familiarizing yourself with this chemical designation is important for scientists in the healthcare industry .

Key aspects regarding Abacavir Sulfate Salt :

  • Purpose: Acts as a nucleoside reverse transcriptase inhibitor .
  • Application : Mainly used in the HIV therapy .
  • Identification : The CAS code 188062-50-2 provides accurate identification .

Decoding Abarelix - Chemical Composition (183552-38-7)

Abarelix, identified by the registration code 183552-38-7, represents a fascinating case within the realm of peptide research. Its intricate arrangement is crucial to its biological effect. Fundamentally, this substance is a synthetic hormone, designed to target and inhibit gonadotropin-releasing GnRH. The molecular formula reveals a sequence of building blocks carefully ordered to ensure a specific binding with the GnRH receptor.

  • Greater investigation are pursued to fully reveal its mechanism of influence.
  • Understanding its creation is vital for increasing manufacture.
  • The exact series dictates its strength.

Abiraterone Acetate (154229-18-2): Uses and Structural Characteristics

{Abiraterone Salt , with the CAS number 154229-18-2, is a pharmaceutical primarily indicated in the treatment of metastatic gland tumor, specifically those exhibiting mutations in the PTEN pathway. It functions as an suppressor of 3β-hydroxycopyright P450c17, an enzyme crucial for androgen production . Chemically, it’s a synthetic compound with a complex makeup, designed to effectively reduce androgen levels. Its medical application has significantly enhanced outcomes for patients with late-stage prostate cancer .

Leave a Reply

Your email address will not be published. Required fields are marked *